Filtered By:
Cancer: Leukemia
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 341 results found since Jan 2013.
Artificial Intelligence and Radiology: The New "Buzz"
What is AI?Here is theWikipedia definition for the beginners: Artificial intelligence (AI) is intelligence exhibited by machines. In computer science, an ideal "intelligent" machine is a flexible rational agent that perceives its environment and takes actions that maximize its chance of success at some goal. Colloquially, the term "artificial intelligence" is applied when a machine mimics "cognitive" functions that humans associate with other human minds, such as "learning" and "problem solving".How does it work in RadiologyArtificial intelligence has serious implications for radiology in particular among other m...
Source: Sumer's Radiology Site - December 11, 2016 Category: Radiology Authors: Sumer Sethi Source Type: blogs
Artificial Intelligence at RSNA: I ' m Sorry, Dave. I ' m Afraid I Won ' t Be Taking Over...
DISCUSSION all over RSNA was Artificial Intelligence, and in particular, AI as applied to Radiology. Well, let ' s be even more specific. There was a cloud (pun intended) hanging over McCormick, the specter of RSNA Yet To Come, which I quite presciently predicted in my 2011RSNA Christmas Carol:I sat down on a PET/CT gantry and bowed my head. The room spun, and when I looked up again, we were seated on a bench beside Lake Michigan. It was a blustery day, with winds one only sees in Chicago in the winter. Strangely, I felt no chill, as I watched leaves blowing through the PACSman ' s shadowy figure.I looked behind me and gas...
Source: Dalai's PACS Blog - December 11, 2016 Category: Radiology Source Type: blogs
Vanessa Bayer
I can tell you I am not Vanessa Bayer ' s biggest fan, because I honestly do not stay up until midnight to watch the show (waaaayyyy past my bedtime). But I am suddenly a hug fan of her openness regarding her leukemia diagnosis.I was getting my hair cut this week and had a chance to catch up on the latest magazines, includingPeople. " When Vanessa Bayer was just freshman in high school, she was diagnosed with leukemia. While the news was a shock for her and her family, Bayer says her cancer battle ultimately led her to a career in comedy.“I wasn’t really that scared,” Bayer says in the latest issue of PEOPLE. ...
Source: Caroline's Breast Cancer Blog - December 10, 2016 Category: Cancer & Oncology Tags: cancer bonds humor medical history Source Type: blogs
The Latest on Chimeric Antigen Receptor Therapy for Leukemia
The use of chimeric antigen receptors (CAR) to create engineered T cells to attack specific varieties of cancer cell, identified by their surface chemistry, is so far proving to be effective for leukemia, a cancer of the immune system. Researchers are also making inroads in adapting the therapy for use in solid tumors. While an initial group of patients treated several years ago with the first pass at CAR T cell therapy remain in remission, the news here focuses on the results from a more recent trial:
The 24 patients had undergone most standard therapies available to them and yet their chronic lymphocytic leukemi...
Source: Fight Aging! - December 6, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Nivolumab with chemotherapy improves response, survival in AML study patients
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled reaction rates and improved overall success in patients with acute myeloid leukemia (AML), according to preliminary findings by researchers at The University of Texas MD Anderson Cancer Center.
Related Posts:CTCA at Western Regional Medical Center advances combinationImmunotherapy with live bacterium improves response rate in…Adjuvant chemotherapy improves overall survival in patients…Drug shows surprising efficacy as therapy for chronic…Experts propose new staging for HPV-related oropharyngeal…The post ...
Source: My Irritable Bowel Syndrome Story - December 5, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Best Post of October 2016: Brain Cancer Surpasses Leukemia as #1 Pediatric Cancer Killer
The next in our " Best of the Month " series comes from October 18, 2016:The following post appeared on the Johns Hopkins Neuropathology Blog last month. The author is Andrew Black:New data from the CDC shows the mortality rates for pediatric cancers is in decline. A study published by the CDC found that during 1999 –2014, the cancer death rate for patients aged 1–19 years in the United States dropped 20%. What is also changing are the type of patients dying. In 1999, leukemia was the leading killer of childhood cancer. That has been replaced by brain cancer. Numerous other trends were also observed in the st...
Source: neuropathology blog - November 28, 2016 Category: Radiology Tags: Best of the Month series facts and figures Source Type: blogs
Smoking Linked to One-Fourth of All US Cancer Deaths
For me personally, the noxious habit of smoking does not seem to exist any more. At home and when traveling to large cities in the U.S., I rarely see anyone smoking. And yet, here's an article that indicates that smoking is linked to one-fourth of all U.S. cancer deaths (see:One-fourth of US cancer deaths linked with 1 thing: smoking). Below is an excerpt from it:Cigarettes contribute to more than 1 in 4 cancer deaths in the U.S. The rate is highest among men in Southern states where smoking is more common and the rules against it are not as strict. The American Cancer Society study found the hi...
Source: Lab Soft News - November 15, 2016 Category: Laboratory Medicine Authors: Bruce Friedman Tags: General Healthcare Medical Consumerism Medical Education Medical Research Preventive Medicine Public Health Informatics Source Type: blogs
Cleveland Clinic ' s Top Ten Medical Innovations for 2017; Focus on FHIR
The Cleveland Clinic lists its choices on a yearly basis for the top ten medical innovations. It recently posted its 2017 list (see:Cleveland Clinic names top 10 medical innovations 2017):The microbiome. The microbiome is made up of trillions of helpful bacteria that make a home inside the human gut – to prevent, treat and diagnose disease.Diabetes drugs that reduce heart disease and death....Novo Nordisk ’s liraglutide, sold as Victoza, and Eli Lilly’s empagliflozin, sold as Jardiance, have shown promise in reducing these heart-related complications (see:Novo Slumps as Study on Victoza ’s Heart Impact Disappoints)...
Source: Lab Soft News - October 31, 2016 Category: Laboratory Medicine Authors: Bruce Friedman Tags: EHR Electronic Health Record (EHR) Healthcare Business Healthcare Delivery Healthcare Information Technology Hospital Executive Management Standards Source Type: blogs
What ’s it like to be a child and your sibling is diagnosed with cancer?
By Christian Jarrett
When the dreadful news arrives that a child has cancer, understandably the focus of parents and health professionals turns to supporting the sick child as best they can. But also caught up in the nightmare are the child’s siblings. Not only will they likely be consumed by shock and fear, but they must adapt to the cancer journey the whole family has to embark on.
Official health guidance here in the UK and in the USA states that it’s important to provide support to the siblings of children with cancer. Yet the reality is we know relatively little about their experience. A new study in Cli...
Source: BPS RESEARCH DIGEST - September 14, 2016 Category: Psychiatry & Psychology Authors: researchdigestblog Tags: Cancer Health Positive psychology Qualitative Source Type: blogs
Health Affairs ’ September Issue: Payment Reforms, Prescription Drugs, And More
The September issue of Health Affairs, a variety issue, includes a number of studies examining aspects of payment reform, the impact of certain ACA provisions, the value of some high-cost anticancer drugs, and more. It also includes a DataGraphic examining aging and health.
DATAWATCH: New evidence of rapid physician practice consolidation, 2013–15
In the past few decades, group physician practices have become more of the norm, and the proportion of physicians in larger groups has grown. David Muhlestein and Nathan Smith, with Leavitt Partners in Salt Lake City, Utah, looked at Medicare’s Physician Compare data for the ...
Source: Health Affairs Blog - September 7, 2016 Category: Health Management Authors: Lucy Larner Tags: Elsewhere@ Health Affairs Featured Health Affairs journal Source Type: blogs
Fight Aging! Newsletter, September 5th 2016
This study is a good example of the degree to which the choice to remain active in later life makes a difference. That implies a range of other choices over the decades in order to raise the odds that you can in fact choose to remain active when older, such as avoiding weight gain.
Moderate physical activity is associated with a greater than 50% reduction in cardiovascular death in over-65s. The 12 year study in nearly 2500 adults aged 65 to 74 years found that moderate physical activity reduced the risk of an acute cardiovascular event by more than 30%. High levels of physical activity led to greater risk reducti...
Source: Fight Aging! - September 4, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
An Investigation of How Telomerase Cancers can Switch to Become ALT Cancers
The paper I'll point out today is a timely one, given that the SENS Research Foundation's fundraiser for early stage work on a therapy for alternative lengthening of telomeres (ALT) cancers is nearing its close. There are still thousands of dollars left in the matching fund, so give it some thought if you haven't yet donated. The search for ways to safely sabotage ALT is a useful, important line of research because (1) blocking telomere lengthening is a path to a universal cancer therapy, (2) those research groups presently working on it are all looking to achieve this goal by interfering in the activities of telomerase, (...
Source: Fight Aging! - September 3, 2016 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Who gets heart cancer?
Over the last quarter of a century, I’ve written about a lot of different aspects of science and medical research. Cancer features a lot, the Big C is prominent in human misery and more common than many other diseases. Often I’ll use a phrase such as “treating liver, bowel, lung, breast, prostate and other cancers”. One phrase I don’t think I’ve ever written, until today is “heart cancer”.
Heart cancer? Do people even get heart cancer? Almost every other organ from skin to brain from gonads to liver, from head and neck to bone and blood, there’s a cancer. Experts repe...
Source: David Bradley Sciencebase - Songs, Snaps, Science - September 2, 2016 Category: Science Authors: David Bradley Tags: Science Source Type: blogs
Fight Aging! Newsletter, July 25th 2016
This study builds on preliminary findings from the first phase of the INTERSTROKE study, which identified ten modifiable risk factors for stroke in 6,000 participants from 22 countries. The full-scale INTERSTROKE study included an additional 20,000 individuals from 32 countries in Europe, Asia, America, Africa and Australia, and sought to identify the main causes of stroke in diverse populations, young and old, men and women, and within subtypes of stroke.
To estimate the proportion of strokes caused by specific risk factors, the investigators calculated the population attributable risk for each factor (PAR; an esti...
Source: Fight Aging! - July 24, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Introducing Viral Cancer Therapies into the Spleen Greatly Improves Outcomes
There are plenty of results from the past decade to illustrate that the methodology by which a therapy is delivered makes a great deal of difference to the outcome in patients. Here, for example, researchers have found a way to improve the performance of viruses engineered to preferentially target cancer cells. We've been hearing less of this approach to cancer in the past few years, given the progress and more widespread support for cancer immunotherapy as a technology platform, but there are still many researchers working on the use of viruses in targeted cancer therapy, and a number of promising studies have resulted.
...
Source: Fight Aging! - July 19, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
